These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12376975)

  • 1. Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.
    Modak S; Gerald W; Cheung NK
    Med Pediatr Oncol; 2002 Dec; 39(6):547-51. PubMed ID: 12376975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
    Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
    Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
    Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
    Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
    Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
    Clin Cancer Res; 1998 Sep; 4(9):2135-9. PubMed ID: 9748131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2.
    Occhino M; Raffaghello L; Burrone O; Gambini C; Pistoia V; Corrias MV; Bestagno M
    Int J Mol Med; 2004 Sep; 14(3):383-8. PubMed ID: 15289889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK; Guo HF; Heller G; Cheung IY
    Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.
    Mujoo K; Cheresh DA; Yang HM; Reisfeld RA
    Cancer Res; 1987 Feb; 47(4):1098-104. PubMed ID: 3100030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
    Zhang S; Zhang HS; Cordon-Cardo C; Ragupathi G; Livingston PO
    Clin Cancer Res; 1998 Nov; 4(11):2669-76. PubMed ID: 9829729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
    Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
    Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
    Kramer K; Gerald WL; Kushner BH; Larson SM; Hameed M; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):194-6. PubMed ID: 11464881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy.
    Fine RL; Shah SS; Moulton TA; Yu IR; Fogelman DR; Richardson M; Burris HA; Samuels BL; Assanasen C; Gorroochurn P; Hibshoosh H; Orjuela M; Garvin J; Goldman FD; Dubovsky D; Walterhouse D; Halligan G
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):429-37. PubMed ID: 16896931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
    Cheung NK; Canete A; Cheung IY; Ye JN; Liu C
    Int J Cancer; 1993 May; 54(3):499-505. PubMed ID: 8509225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
    Zhang PJ; Goldblum JR; Pawel BR; Fisher C; Pasha TL; Barr FG
    Mod Pathol; 2003 Mar; 16(3):229-35. PubMed ID: 12640103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside antigens expressed by human cancer cells.
    Ritter G; Livingston PO
    Semin Cancer Biol; 1991 Dec; 2(6):401-9. PubMed ID: 1810468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.
    Schulz G; Cheresh DA; Varki NM; Yu A; Staffileno LK; Reisfeld RA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5914-20. PubMed ID: 6498849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.